Jacob M van Laar

14PUBLICATIONS
73CO-AUTHORS
Arts therapyCardiology (incl. cardiovascular diseases)Major global burdens of diseaseMolecular medicineRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Sep 25, 2025
HandScan criteria versus ACR/EULAR Boolean remission as treatment target in early rheumatoid arthritis: results of a randomized controlled trial.

Matthijs S van der Leeuw, Paco M J Welsing, Janneke Tekstra

|Feb 26, 2025
Evaluation of Systemic Sclerosis Primary Heart Involvement and Chronic Heart Failure in the European Scleroderma Trials and Research Cohort.

Andrea-Hermina Györfi, Tim Filla, Amin Polzin

|Oct 09, 2024
Difficult-to-treat rheumatoid arthritis: what have we learned and what do we still need to learn?

Zonne L M Hofman, Nadia M T Roodenrijs, Elena Nikiphorou

|Jan 31, 2024
A phase 2 trial investigating the efficacy and safety of the mPGES-1 inhibitor vipoglanstat in systemic sclerosis-related Raynaud's.

Göran Tornling, Charlotte Edenius, John D Pauling

|Jul 05, 2022
Identifying relevant determinants of in-hospital time to diagnosis for ANCA-associated vasculitis patients.

Ebru Dirikgil, Sander W Tas, Cornelis A Verburgh

|Mar 14, 2022
Systemic glucocorticoid use and the occurrence of flares in psoriatic arthritis and psoriasis: a systematic review.

Nanette L A Vincken, Deepak M W Balak, André C Knulst

Pageof 3